Pharmacologic Therapy in Men’s Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia
Medical Clinics of North America(2016)
摘要
This article reviews current pharmacologic treatment options for 3 common men's health concerns: hypogonadism, erectile dysfunction (ED), and benign prostatic hyperplasia (BPH). Specific topics addressed include: management of male hypogonadism using testosterone replacement therapy, use of oral phosphodiesterase inhibitors as first-line therapy for men with ED and the utility of intraurethral and intrapenile alprostadil injections for patients who do not respond to oral medications, and the role of alpha1-adrenergic antagonists, 5-alpha-reductase inhibitors, anticholinergic agents, and herbal therapies in the management of BPH.
更多查看译文
关键词
Male hypogonadism,Erectile dysfunction (ED),Benign prostatic hyperplasia (BPH),Pharmacologic treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要